- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Secondary Prevention in Russian Federation
Total 42 results
-
Federal State Budgetary Scientific Institution...CompletedPrevention of Diseases of the Musculoskeletal SystemRussian Federation
-
Federal State Budgetary Scientific Institution...CompletedPrevention of Diseases of the Musculoskeletal SystemRussian Federation
-
Federal State Budgetary Scientific Institution...CompletedPrevention of Diseases of the Musculoskeletal SystemRussian Federation
-
Human Stem Cell Institute, RussiaRussian Academy of Medical SciencesUnknownSecondary Raynaud's PhenomenonRussian Federation
-
Research and Practical Clinical Center for Diagnostics...CompletedPrevention, Arterial HypertensionRussian Federation
-
National Research Center for Preventive MedicineThe League of Clinical Research, RussiaCompleted
-
Gamaleya Research Institute of Epidemiology and...Government of the city of Moscow; CRO: Crocus Medical BVUnknownCovid19 PreventionRussian Federation
-
BayerActive, not recruitingPrevention of Vitamin Deficiency During and/or Before PregnancyRussian Federation, Kazakhstan, Uzbekistan
-
Gamaleya Research Institute of Epidemiology and...Russian Direct Investment FundActive, not recruitingCOVID-19 PreventionRussian Federation
-
Gamaleya Research Institute of Epidemiology and...CREMS (Centre de Recherche Epidémiologie, Microbiologie et Soins médicaux )CompletedEbola Virus Disease | PreventionRussian Federation, Guinea
-
Saint Petersburg State University, RussiaCompletedHypocalcemia | Secondary Hyperparathyroidism | Dialysis | Hypoparathyroidism | Chronic Kidney Disease-Mineral and Bone DisorderRussian Federation
-
Moscow State University of Medicine and DentistryRecruitingBenign Prostatic HyperplasiaRussian Federation
-
Gamaleya Research Institute of Epidemiology and...Acellena Contract Drug Research and DevelopmentCompletedPreventive Immunization COVID-19Russian Federation
-
Gamaleya Research Institute of Epidemiology and...Acellena Contract Drug Research and DevelopmentCompletedPreventive Immunization COVID-19Russian Federation
-
Boehringer IngelheimCompletedVenous Thromboembolism | Secondary PreventionUnited States, Norway, Canada, Belgium, Thailand, Italy, Germany, Turkey, Austria, Hungary, Czechia, Taiwan, Israel, Brazil, Denmark, France, Lithuania, Mexico, Russian Federation, Sweden, Switzerland, Ukraine
-
Saint Petersburg State University, RussiaCompletedSecondary Hyperparathyroidism | Dialysis | Vascular Calcification | Chronic Kidney Disease Mineral and Bone DisorderRussian Federation
-
Gamaleya Research Institute of Epidemiology and...Government of the city of Moscow; Russian Direct Investment Fund; CRO: iPharmaUnknownCOVID-19 PreventionRussian Federation
-
AbbVie (prior sponsor, Abbott)AlmedisCompletedSecondary HyperparathyroidismRussian Federation
-
ValexfarmCompletedEpilepsy | Complex Partial Seizures | Simple Partial Seizures | Partial Seizures With Secondary GeneralizationRussian Federation
-
Boehringer IngelheimCompletedStroke | Secondary PreventionKorea, Republic of, United States, Spain, Canada, Germany, Taiwan, Belgium, Australia, Hong Kong, India, Singapore, Thailand, Greece, Italy, Japan, China, Turkey, Russian Federation, Serbia, Switzerland, Israel, South Africa, Malaysia, Fran... and more
-
European Society for Blood and Marrow TransplantationPierre Fabre MedicamentTerminatedMyelodysplastic Syndromes | Secondary Acute Myeloid LeukemiaGermany, Italy, Netherlands, Russian Federation
-
Materia Medica HoldingCompletedPreventive MedicineRussian Federation, Uzbekistan
-
AmgenCompletedSecondary Hyperparathyroidism, Chronic Kidney DiseaseUnited States, Czechia, Germany, France, Hungary, Greece, Belgium, Italy, Poland, Russian Federation, Ukraine
-
AmgenTerminatedChronic Kidney Disease, Secondary HyperparathyroidismUnited States, Belgium, Italy, Hungary, Czechia, France, Germany, Greece, Spain, Poland, Russian Federation, Ukraine, New Zealand, Slovakia, Lithuania, Portugal
-
AmgenTerminatedHyperparathyroidism | Chronic Kidney Disease | Secondary Hyperparathyroidism | Hyperparathyroidism, Secondary | Kidney DiseaseUnited States, Belgium, Hungary, Spain, Australia, Germany, Poland, Mexico, Russian Federation, Slovakia
-
AbbottCompletedHemodialysis | Chronic Kidney Disease | Secondary HyperparathyroidismUnited States, Czech Republic, Denmark, Germany, Greece, Italy, Netherlands, Portugal, Russian Federation, Spain, Sweden, United Kingdom
-
Swedish Orphan BiovitrumTerminatedPrevention of Growth RestrictionBelgium, France, Germany, Hungary, Italy, Poland, Spain, Sweden, Czech Republic, Russian Federation
-
AmgenRecruitingChronic Kidney Disease | Secondary HyperparathyroidismKorea, Republic of, United States, India, Singapore, Taiwan, Argentina, Malaysia, Russian Federation, Turkey, Ukraine
-
Bellus Health IncFDA Office of Orphan Products DevelopmentCompletedGastrointestinal Diseases | Kidney Diseases | Rheumatoid Arthritis | Nephrotic Syndrome | Secondary (AA) Amyloidosis | Familial Mediterranean SyndromeUnited States, Israel, Finland, France, Italy, Lithuania, Netherlands, Poland, Russian Federation, Spain, Turkey, United Kingdom
-
Antisoma ResearchUnknownSecondary Acute Myeloid Leukemia (Secondary AML, sAML)Korea, Republic of, United States, Spain, United Kingdom, Australia, Austria, Taiwan, Israel, Italy, Belgium, Germany, France, Romania, Estonia, Canada, Ukraine, Ecuador, Hungary, Poland, Chile, Argentina, Czech Republic, Russian Federation
-
AmgenTerminatedChronic Kidney Disease | Hyperparathyroidism, SecondaryUnited States, Belgium, Italy, Hungary, Czechia, France, Germany, Poland, Netherlands, Russian Federation, New Zealand, Mexico, Slovakia
-
AmgenCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States, Italy, Belgium, Denmark, Switzerland, Canada, Turkey, Spain, Austria, Germany, Hungary, Greece, France, Poland, Russian Federation, Czechia, Latvia, Lithuania, New Zealand, Portugal, Sweden, Estonia
-
BiogenTerminatedSecondary Progressive Multiple SclerosisUnited States, Finland, Italy, Spain, Canada, France, Israel, Sweden, Netherlands, Belgium, Poland, United Kingdom, Czechia, Denmark, Russian Federation, Germany, Ireland
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Italy, United Kingdom, Canada, Germany, Spain, Austria, Czechia, Hungary, France, Israel, Poland, Australia, Russian Federation
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Canada, France, Australia, Israel, Czechia, Hungary, Netherlands, Spain, Poland, Russian Federation, Italy, Sweden, Germany
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Italy, Switzerland, Canada, Turkey, Spain, Australia, Austria, Israel, Czechia, Hungary, Poland, France, Russian Federation, Germany, Denmark, Greece, Latvia, Lithuania, Netherlands, New Zealand, Portugal, Sweden
-
SanofiActive, not recruitingSecondary Progressive Multiple SclerosisUnited States, Argentina, Belgium, Canada, Czechia, France, Germany, Greece, India, Israel, Netherlands, Norway, Portugal, Turkey, United Kingdom, Japan, Austria, Bulgaria, China, Denmark, Finland, Italy, Lithuania, Poland, Romania, Russian... and more
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple SclerosisChina, Germany, United States, Romania, Italy, Austria, Belgium, Czechia, Spain, Australia, Canada, France, Israel, Switzerland, Japan, Bulgaria, Netherlands, United Kingdom, Estonia, Latvia, Lithuania, Russian Federation, Turkey, Slo... and more
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Italy, United Kingdom, Canada, Germany, Spain, Australia, Austria, Israel, Czechia, Hungary, Netherlands, Poland, France, Russian Federation, Sweden
-
BayerJanssen Research & Development, LLC; Population Health Research InstituteCompletedPrevention & ControlBelgium, Finland, France, China, United States, Colombia, Ireland, Philippines, Japan, Hungary, Canada, Germany, Australia, Chile, Czechia, Korea, Republic of, Malaysia, Brazil, Denmark, Israel, Russian Federation, South Africa, Ecu... and more
-
BayerCompletedHemodialysis | End-stage Renal Disease | Hemodiafiltration | Prevention of Thromboembolic EventsSpain, Greece, Belgium, Russian Federation, Netherlands, Turkey, Japan, Australia, Austria, Bulgaria, Italy, Ukraine, Czechia, Israel, United States, Hungary, Lithuania, Poland, Portugal
-
IpsenCompletedRetention Disorders, Cognitive | Memory Disorders, Age-RelatedFrance